Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Mark Foster
AddedMar 31, 2024
UpdatedMay 31, 2026
Mark Foster

Mark Foster

CEO, Trice Orthopedics

CrunchbaseLinkedIn

Mark Foster's Career

Trice Orthopedics
Trice Orthopedics

King of Prussia, PA, US

CEO· C-Suite · Management
Trice Medical
Trice Medical

Malvern, PA, US

CEO· C-Suite · Management
ZetrOZ Systems
ZetrOZ Systems

Trumbull, CT, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Mark Foster's Career

Trice Orthopedics
Trice Orthopedics
Seed$3M112012King of Prussia, PA, US
CEO· C-Suite · Management

Similar to Trice Orthopedics

Trice MedicalTrice MedicalMalvern, PA, USMedical Devicesest. 2012Trice MedicalMalvern, PA, US · est. 2012

Trice Medical: Providing micro-invasive orthopedic diagnostic devices and patient care solutions in Pennsylvania.

Series A · $106.2M52
Ortho KinematicsOrtho KinematicsAustin, TX, USMedical Devicesest. 2006Ortho KinematicsAustin, TX, US · est. 2006

Ortho Kinematics, Inc.: Innovating spine diagnostics with automated, functional motion analysis equipment.

Series D · $53.6M31
Triage MedicalTriage MedicalIrvine, CA, USest. 2000Triage MedicalIrvine, CA, US · est. 2000

Innovative orthopedic trauma device manufacturer in Irvine, CA.

Series B · $10M50
Orthopedic Wellness LaboratoriesOrthopedic Wellness LaboratoriesWoodinville, WA, USDiagnostics, Healthcareest. 2017Orthopedic Wellness LaboratoriesWoodinville, WA, US · est. 2017

Orthopedic Wellness Laboratories provides innovative, precise range of motion diagnostic technology.

Seed · $225k11
Trice Medical
Trice Medical
Series A$106.2M522012Malvern, PA, US
CEO· C-Suite · Management

Leadership at Trice Medical

Jeffrey O'Donnell Sr.Jeffrey O'Donnell Sr.Founder
Bill HawkinsBill HawkinsBoard Member
Jeff O'DonnellJeff O'DonnellBoard Member
ZetrOZ Systems
ZetrOZ Systems
Series B$12.9M302009Trumbull, CT, US
Board Member· Board

Leadership at ZetrOZ Systems

Jeffrey PurvinJeffrey PurvinBoard Member
George LewisGeorge LewisCo-Founder
Bryant GuffeyBryant GuffeyCo-Founder
Bill JollyBill JollyBoard Member

Similar to ZetrOZ Systems

Zenith Technical InnovationsZenith Technical InnovationsGurnee, IL, USMedical Devicesest. 2014Zenith Technical InnovationsGurnee, IL, US · est. 2014

Zenith Technical Innovations: Illinois-based medical device manufacturer and distributor, specializing in versatile therapy solutions.

Seed · $3.1M3
OtoNexus Medical TechnologiesOtoNexus Medical TechnologiesSeattle, WA, USMedical Devicesest. 2010OtoNexus Medical TechnologiesSeattle, WA, US · est. 2010

Seattle-based OtoMetrix creates OtoStat, a Doppler ultrasound device for diagnosing ear infections.

Series B · $19.3M20
Sanuwave HealthSanuwave HealthSuwanee, GA, USMedical Devicesest. 2004Sanuwave HealthSuwanee, GA, US · est. 2004

Global provider of energy transfer technology for regenerative therapies and non-medical systems.

Public · $47.7M38
ZSX MedicalZSX MedicalPhiladelphia, PA, USMedical Devicesest. 2009ZSX MedicalPhiladelphia, PA, US · est. 2009

ZSX Medical, LLC: Innovating minimally-invasive surgery with Zip-stitch, a surgical closure system enhancing patient outcomes.

Series A · $3.7M11

Mark Foster's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to Mark Foster

Thomas KetchellThomas KetchellCo-Founder & CEO · SutoriPaul McCulleyPaul McCulleyCEO · TheFix.comBen SimpsonBen SimpsonCo-Founder & CEO · EasolMichael EgorovMichael EgorovCo-Founder · NuCypherJohn EvansJohn EvansCEO · AccufixJeff RydinJeff RydinBoard Member · Minimally Invasive Devices